Sialylation-related gene signature predict prognosis and immunotherapy efficacy in low- and high-grade glioma: a PCA-based stratification study
We developed a robust model to predict patient prognosis in low-grade gliomas and glioblastomas, emphasizing the prognostic significance of differentially expressed genes associated with sialylation.
Authors
- Rentong Liu (ORCID: https://orcid.org/0009-0005-5041-0627)
- Chengke Zhang
- Yan Liu (ORCID: https://orcid.org/0000-0001-7547-8699)
- Chengwei Wang
- Gang Xin
- Gui‐Dong Zhu
Institutions
- Qingdao University (CN)
- Union Hospital (HK)
- Second Hospital of Shandong University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Affiliated Hospital of Shandong Academy of Medical Sciences (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-12-09
- DOI
- https://doi.org/10.3389/fonc.2025.1676103
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00